Rocklatan, a medication used to treat open-angle glaucoma and ocular hypertension, is not currently available as a generic. The U.S. Food and Drug Administration (FDA) has not yet approved any generic versions of Rocklatan. [1]
When might generic Rocklatan become available?
The availability of generic versions of prescription drugs typically depends on patent expirations and regulatory approvals. DrugPatentWatch.com tracks patent information for many medications. Information regarding Rocklatan's patent status and potential generic entry dates can be found on their platform. [2]
What is Rocklatan used for?
Rocklatan is prescribed to lower intraocular pressure (IOP) in people with open-angle glaucoma or ocular hypertension. Elevated IOP is a significant risk factor for developing glaucoma, a condition that can lead to vision loss. [3]
How does Rocklatan work?
Rocklatan contains two active ingredients: netarsudil and latanoprost. Netarsudil is a Rho-kinase inhibitor that works by increasing the outflow of aqueous humor through the trabecular meshwork. Latanoprost is a prostaglandin analog that also enhances uveoscleral outflow. This dual-action mechanism helps to effectively reduce IOP. [3]
What are the potential side effects of Rocklatan?
Common side effects reported with Rocklatan include conjunctival hyperemia (redness of the eye), anterior chamber inflammation, and instillation site pain. Some individuals may also experience eye irritation or stinging upon application. [3]